22 May 2013
Keywords: millennium, velcade, fda, fast-track, new, use, pharmaceuticals
Article | 08 November 2004
Millennium Pharmaceuticals of the USA says that the US Food and Drug Administration has awarded its Velcade (bortezomib) fast-track status
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 November 2004
15 November 2004
© 2013 thepharmaletter.com